Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Han T. Cun"'
Autor:
Miranda P. Steenbeek, Majke H.D. van Bommel, Johan Bulten, Julia A. Hulsmann, Joep Bogaerts, Christine Garcia, Han T. Cun, Karen H. Lu, Heleen J. van Beekhuizen, Lucas Minig, Katja N. Gaarenstroom, Marielle Nobbenhuis, Mateja Krajc, Vilius Rudaitis, Barbara M. Norquist, Elizabeth M. Swisher, Marian J.E. Mourits, Leon F.A.G. Massuger, Nicoline Hoogerbrugge, Rosella P.M.G. Hermens, Joanna IntHout, Joanne A. de Hullu
Publikováno v:
J Clin Oncol
Journal of Clinical Oncology, 40(17), 1879-1891. American Society of Clinical Oncology
Journal of Clinical Oncology, 40(17), 1879-+. LIPPINCOTT WILLIAMS & WILKINS
Journal of Clinical Oncology, 40, 17, pp. 1879-1891
Journal of Clinical Oncology, 40(17), 1879-1891. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 40, 1879-1891
Journal of Clinical Oncology, 40(17), 1879-1891. American Society of Clinical Oncology
Journal of Clinical Oncology, 40(17), 1879-+. LIPPINCOTT WILLIAMS & WILKINS
Journal of Clinical Oncology, 40, 17, pp. 1879-1891
Journal of Clinical Oncology, 40(17), 1879-1891. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 40, 1879-1891
PURPOSE After risk-reducing salpingo-oophorectomy (RRSO), BRCA1/ 2 pathogenic variant (PV) carriers have a residual risk to develop peritoneal carcinomatosis (PC). The etiology of PC is not yet clarified, but may be related to serous tubal intraepith
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1353d6db4e49aa6c2b881b6b19020cf8
https://doi.org/10.1200/JCO.21.02016
https://doi.org/10.1200/JCO.21.02016
Autor:
Yulia Lakhman, Mario M. Leitao, Anuja Jhingran, Olga T. Filippova, Eric Rios-Doria, Lora H. Ellenson, Kaled M. Alektiar, Vicky Makker, Jennifer J. Mueller, Pamela T. Soliman, Han T. Cun, Nadeem R. Abu-Rustum
Publikováno v:
Gynecologic Oncology. 162:S193-S194
Objectives: To compare clinical and pathologic characteristics of women with surgical stage I endometrial cancer by location of first recurrence; to describe characteristics of isolated vaginal recurrence. Methods: All women with surgical stage I end
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43a8f3fc215b4fae6e2854b7c943545c
https://doi.org/10.1016/s0090-8258(21)01017-9
https://doi.org/10.1016/s0090-8258(21)01017-9
Autor:
Stephen T. C. Wong, Samuel C. Mok, Rita Cheng, Jae Hoon Kim, Gwan Hee Han, Karen H. Lu, Han T. Cun, Ying Zhu, Sammy Ferri Borgogno, Jianting Sheng
Publikováno v:
Gynecologic Oncology. 162:S110-S111
Objectives: Based on differences in chemosensitivity and clinical outcomes, we hypothesize that clear cell ovarian carcinoma (CCCO) may display a unique tumor immune microenvironment compared to high grade serous ovarian carcinoma (HGSOC). In additio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3c2719c74b0fa0fb2e29a750a863684
https://doi.org/10.1016/s0090-8258(21)00852-0
https://doi.org/10.1016/s0090-8258(21)00852-0
Autor:
Xinyuan Guan, Rohinton Tarapore, Tsz-Lun Yeung, Li Zhang, Han T. Cun, Chi Lam Au-Yeung, Sammy Ferri-Borgogno, Suet Ying Kwan, Wen Hu, Joshua E. Allen, Kelsey E. Lewis, Pamela T. Soliman, Karen H. Lu, Samuel C. Mok
Publikováno v:
Cancers
Volume 12
Issue 9
Cancers, Vol 12, Iss 2436, p 2436 (2020)
Volume 12
Issue 9
Cancers, Vol 12, Iss 2436, p 2436 (2020)
Uterine serous cancer (USC) is an aggressive subtype of endometrial cancer, with poor survival and high recurrence rates. The development of novel and effective therapies specific to USC would aid in its management. However, few studies have focused
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::747d89a13528e35f425ee08426bb50b9
Autor:
Han T. Cun, Karen H. Lu
Publikováno v:
Obstetrics and gynecology. 135(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d00392cf15f69457b017938ba7181de3
https://pubmed.ncbi.nlm.nih.gov/32028491
https://pubmed.ncbi.nlm.nih.gov/32028491
Autor:
Rita Cheng, Ying Zhu, Jae Hoon Kim, Samuel C. Mok, Stephen T. C. Wong, Gwan Hee Han, Karen H. Lu, Han T. Cun, Sammy Ferri-Borgogno, Jianting Sheng
Publikováno v:
Cancer Research. 81:2749-2749
Based on differences in chemosensitivity and clinical outcomes, we hypothesize that clear cell ovarian carcinoma (CCCO) displays a unique tumor immune microenvironment (TIME) compared to high grade serous ovarian carcinoma (HGSOC). Microsatellite ins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10a01588c3ab6b0ad8b5a7fc26f7b719
https://doi.org/10.1158/1538-7445.am2021-2749
https://doi.org/10.1158/1538-7445.am2021-2749
Autor:
Gwan Hee Han, Sammy Ferri-Borgogno, Jared K. Burks, Samuel C. Mok, Karen H. Lu, Han T. Cun, Rita Cheng, Jae Hoon Kim
Publikováno v:
Cancer Research. 81:2744-2744
By examining the immune landscape in recurrent ovarian carcinoma, we can characterize the evolution of the tumor immune microenvironment (TIME) to understand its disease progression and response to therapy. Thus, the objective of this study is to eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38187f82e914f5ab3fe7dc45f3ac93ae
https://doi.org/10.1158/1538-7445.am2021-2744
https://doi.org/10.1158/1538-7445.am2021-2744
Autor:
Kelsey E. Lewis, Li Zhang, Rohinton Tarapore, Xinyuan Guan, Karen H. Lu, Pamela T. Soliman, Sammy Ferri-Borgogno, Chi-Lam Au-Yeung, Suet-Ying Kwan, Wen Hu, Tsz-Lun Yeung, Joshua E. Allen, Samuel C. Mok, Han T. Cun
Publikováno v:
Cancers
Cancers, Vol 13, Iss 623, p 623 (2021)
Cancers, Vol 13, Iss 623, p 623 (2021)
Uterine serous cancer (USC) is an aggressive subtype of endometrial cancer, with poor survival and high recurrence rates. The development of novel and effective therapies specific to USC would aid in its management. However, few studies have focused
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfeefc04c446b96333f83d02e4cc98b0
https://doi.org/10.3390/cancers13040623
https://doi.org/10.3390/cancers13040623
Autor:
Jianting Sheng, Gwan Hee Han, Han T. Cun, Samuel C. Mok, Sammy Ferri-Borgogno, Joseph Celestino, Rita Cheng, Jae Hoon Kim, Karen H. Lu, Stephen T. C. Wong
Publikováno v:
Gynecologic Oncology. 159:26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb4dd58abd1185fb96ef26e02a81f145
https://doi.org/10.1016/j.ygyno.2020.06.055
https://doi.org/10.1016/j.ygyno.2020.06.055
Autor:
Han T. Cun, Stephen T. C. Wong, Rita Cheng, Ying Zhu, Emily Hinchcliff, Jared K. Burks, Samuel C. Mok, Amir A. Jazaeri, Sammy Ferri-Borgogno
Publikováno v:
Cancer Research. 80:3267-3267
The role of immune checkpoint inhibitors (ICPIs) in ovarian cancer continues to be refined. The presence of intratumoral T cells in ovarian tumors correlates with improved survival and progression, suggesting that immune modulation, such as by ICPIs,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0b0d83aea9f8898bc886b45d623b70c
https://doi.org/10.1158/1538-7445.am2020-3267
https://doi.org/10.1158/1538-7445.am2020-3267